Tech Company Financing Transactions
Otonomy Funding Round
Otonomy, operating out of San Diego, received $10 million from Avalon Ventures.
Transaction Overview
Company Name
Announced On
6/11/2010
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Avalon Ventures (Jay Lichter)
Proceeds Purpose
Proceeds from the financing will be used to support the ongoing clinical trial for OTO-104 in Meniere's disease, initiate IND-enabling studies for OTO-203, and continue early-stage development of a third program.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4796 Executive Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Otonomy (NASDAQ: OTIC) is a biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Weber
Chief Financial Officer
Paul Cayer
Chief Technical Officer
Robert Savel
VP - Finance
Julie Burgess
VP - Human Resources
Carla da Luz Boren
Browse more venture capital transactions:
Prev: 6/11/2010: Kaazing venture capital transaction
Next: 6/11/2010: Igenica venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs